Inogen’s Q4 Revenue Beat Overshadowed by Lack of Guidance, Earning a Hold Rating
Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Inogen (INGN – Research Report) yesterday and set a price target of ...
Hosted on MSN18d
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device
In October this year, the company commenced the US market release of the ‘Inogen Rove 4 Portable Oxygen Concentrator’. The Rove 4 incorporates the company’s patented pulse-dose Intelligent ...
CNN4y
Inogen, Inc.
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...
Nasdaq18d
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
Recent Development for INGN In October, INGN announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 utilizes Inogen’s patented ...
Cautious Hold Rating on Inogen Amid Mixed Growth Signals and Business Challenges
Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating yesterday.Stay Ahead of the ...